retatrutide phase 2 weight loss results trial obesity Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized 2a with retatrutide as – Retatrutide for Weight Loss: TRIUMPH-1

Dietary medium-chain triglyceride decanoate affects glucose homeostasis through GPR84-mediated GLP-1 secretion in mice

Other GLP-1 receptor agonists licensed in the UK include dulaglutide (Trulicity), exenatide (Byetta, Bydureon), and lixisenatide (Lyxumia)

Whats your take on the rapid evolution of multi-receptor GLP-1 therapies vs

It generally works better for people who want to reduce their drinking than for people whose primary goal is long-term abstinence, where acamprosate may have an advantage

GLP-1 receptor agonists are positioned as one of the pharmacotherapeutic options that can contribute to addressing the high unmet medical need characterizing several prevalent aging-related diseases, making them ideal for our longevity-focused approach

GLP-1 medications generally permitted with proper documentation Singapore : Requires original prescription and limits quantities to personal use China : Complex importation rules